New immunotherapy trial targets Hard-to-Treat prostate cancer

NCT ID NCT06533644

Recruiting now Disease control Sponsor: Syncromune, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment called SYNC-T therapy (SV-102) for men with metastatic castration-resistant prostate cancer, a type that has stopped responding to hormone therapy. The goal is to find the safest and most effective dose and see if it can shrink tumors. About 91 men will take part in this early-phase trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Arkansas Urology
NOT_YET_RECRUITING

Little Rock, Arkansas, 72211, United States
Duly Health
RECRUITING

Lisle, Illinois, 60532, United States
Houston Metro Urology
NOT_YET_RECRUITING

Houston, Texas, 77027, United States
Mayo Clinic
NOT_YET_RECRUITING

Phoenix, Arizona, 85054, United States
Mayo Clinic
NOT_YET_RECRUITING

Jacksonville, Florida, 32224, United States
Medical College of Wisconsin
NOT_YET_RECRUITING

Milwaukee, Wisconsin, 53226, United States
Mercy Hospital
RECRUITING

St Louis, Missouri, 63141, United States
Michigan Institute of Urology
RECRUITING

Troy, Michigan, 48084, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
NYU Langone
RECRUITING

New York, New York, 10016, United States
Northwell Health
RECRUITING

Lake Success, New York, 11042, United States
Ohio State University
RECRUITING

Columbus, Ohio, 43201, United States
Summit Urology
NOT_YET_RECRUITING

Murray, Utah, 84107, United States
Thomas Jefferson University
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19107, United States
University of Arizona Cancer Center
RECRUITING

Tucson, Arizona, 85719, United States
University of California-Davis
RECRUITING

Sacramento, California, 95817, United States
University of Chicago
NOT_YET_RECRUITING

Chicago, Illinois, 60637, United States
University of Miami
RECRUITING

Miami, Florida, 33136, United States
University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68105, United States
University of Pittsburgh Medical Center
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
Weill Cornell
RECRUITING

New York, New York, 10065, United States
Wichita Urology
RECRUITING

Wichita, Kansas, 67226, United States
Willis Knighton
NOT_YET_RECRUITING

Shreveport, Louisiana, 71105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.